Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...

cDNA microarray technology provides a novel approach to identify individual target genes and survey global genetic programs under the control of specific signalling pathways in mammalian systems.

The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...

Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...

With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...

Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...

Apple Freeform is a versatile digital tool designed to help you brainstorm, plan, and organize ideas on an infinite canvas. Whether you're a creative professional, a student, or a team leader, ...

Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...

The global metagenomics sequencing market size was US$ 1139.3 million in 2021. The global metagenomics sequencing market is forecast to grow to US$ 3,994.01 million by 2030 by registering a compound ...

Whole-genome arrays have been used to reveal small islands of genetic differentiation in Anopheles mosquitoes. Analysis of these regions will identify genes involved in the initial stages of ...